Showing 31-35 of 169 news & articles:
What strategies are being employed to accelerate product development and commercialization without compromising quality?

Pharma’s Almanac March 8, 2024 Read the full article >> Richard Gliklich, M.D., Chief Executive Officer, OM1, Inc. One of the most promising paths being applied to accelerate product development and commercialization comes in the form of real-world data/evidence (RWD/RWE) and applied AI. In clinical development, we are using de-identified RWD to identify clinical sites with eligible[…]

Promise of AI in MS Research and Treatment Showcased at ACTRIMS 2024

March 3, 2024 Kyle Munz AJMC Read the full article >> The use of artificial intelligence (AI) in medical practice and research has gained lots of traction and popularity. At this point, discoveries and advancements in this area may feel like a weekly occurrence. As these methods start becoming more commonplace, it’s no surprise the[…]

Machine learning model could assist in treatment of MS

Healio March 1, 2023 Robert Herpen Read the full article >> Key takeaways: A machine-learning model produced 46,644 estimated scores on a disability scale from 3,404 scores. Application could increase study volunteers and create potential for a tool to tailor treatment plans. WEST PALM BEACH, Fla. — Application of a machine learning model to databases[…]

Navigating Rare Dermatologic Diseases Using Artificial Intelligence

Dermatology Times February 29, 2024 Kaitlyn Bader, Senior Editor Joseph Zabinski, PhD, MEM Read the full article >> This Rare Disease Day, Joseph Zabinski, PhD, MEM, of OM1, discusses the role of artificial intelligence in helping to detect rare dermatologic diseases. Rare Disease Day has been observed globally every year on the last day of[…]

1 … 5 6 7 8 9 … 34